Global Epigenome Analysis Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
|
Market Size (Forecast Year) |
|
CAGR |
|
Major Markets Players |
全球表观基因组分析市场,按技术(Elisa、ChIP Qpcr、ChIP‐on‐Chip、其他)、成分(乙基化、乙酰化、磷酸化、泛素化、SUMO化)、方法(DNA 甲基化分析、DNA/蛋白质相互作用分析、染色质可及性、构象分析)、最终用户(学术和研究机构、制药公司、生物技术公司、合同研究组织)划分 - 行业趋势和预测到 2030 年。
表观基因组分析市场分析和规模
根据 NCI 的数据,美国每年的癌症死亡率为每 100,000 名男性和女性 163.5 人。国际癌症基因组联盟 (ICGC) 正在努力表征肿瘤基因组学、表观基因组学变化和转录组学变化。癌症患病率上升、慢性病患病率上升以及老年人口不断增长,所有这些因素都有望推动市场增长。
Data Bridge Market Research 分析,表观基因组分析市场在 2022 年的规模为 14.7 亿美元,预计到 2030 年将达到 45 亿美元,在 2023 年至 2030 年的预测期内的复合年增长率为 15%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
表观基因组分析市场范围和细分
报告指标 |
细节 |
预测期 |
2023 至 2030 年 |
基准年 |
2022 |
历史岁月 |
2021(可定制为 2015 - 2020) |
定量单位 |
收入(单位:十亿美元)、销量(单位:台)、定价(美元) |
涵盖的领域 |
技术(Elisa、ChIP Qpcr、ChIP‐on‐Chip、其他)、成分(乙基化、乙酰化、磷酸化、泛素化、SUMO化)、方法(DNA 甲基化分析、DNA/蛋白质相互作用分析、染色质可及性、构象分析)、最终用户(学术和研究机构、制药公司、生物技术公司、合同研究组织) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
涵盖的市场参与者 |
Illumina, Inc. (U.S.), Merck KGaA (Germany), QIAGEN (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Eisai Co., Ltd. (Japan), Novartis AG (Switzerland), Abcam plc (U.K.), Diagenode s.a. (U.S.), Active Motif, Inc. (U.S.), Zymo Research Corporation. (U.S.), Thermo Fisher Scientific (U.S.), Cellcentric (Germany), Syndax (U.S.), New England Biolabs (U.S.), Epizyme, Inc. (U.S.), Domainex (U.K.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), AsisChem Inc. (US), Enzo Life Sciences, Inc. (U.S.), EpiGentek Group Inc. (U.S.), BioVision Inc. (U.S.), Bio-Techne. (U.S.), Promega Corporation (U.S.), GeneTex, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.) |
Market Opportunities |
|
Market Definition
Epigenetics is the study of changes in gene function that occur without any changes in the DNA sequence. Several previous studies have suggested that epigenetic changes are heritable. This subproject focuses on the epigenetic mechanism of DNA methylation, which can be measured in-house using the Infinium HumanMethylation450 BeadChip or our implemented NGS-based Reduced Representation Bisulfite Sequencing (RRBS) protocol. All bioinformatics tools required for detecting differentially methylated regions in RRBS NGS data are available.
Global Epigenome Analysis Market Dynamics
Drivers
- Rising research and development activities
Organizations such as the International Human Epigenome Consortium (IHEC), the National Cancer Institute (NCI), and the National Institute of Health (NIH) are influencing market growth. These organizations advocate for funding and support for research and development in epigenetics. The National Institutes of Health funds epigenetics research through a common fund epigenomics programme, which actively supports new epigenetic research around the world. Rising demand for understanding epigenetic modifications at the molecular level and developing therapeutic solutions will likely motivate these organizations to fund research and development programmes. Furthermore, initiatives such as the Epidemiology and Genomics Research Program (EGRP) provide incentives for research activities aimed at better understanding cancer causes and outcomes.
- Government Initiatives
The Encyclopedia of DNA Elements (ENCODE) project was initiated by the National Human Genome Research Institute in the United States with the goal of identifying all of the human genome sequence functional elements. The NIH-funded International Human Epigenome Consortium (IHEC) is also involved in generating and analyzing epigenomic data that epigenomic researchers can use. Most epigenetics research aims to identify treatment options for various types of tumours.
Opportunities
- Increasing geriatric population
A rise in the geriatric population is expected to boost market growth. According to WHO, the global population of people aged 65 and up is expected to grow from 1 billion in 2019 to approximately 1.4 billion by 2030 and 2.1 billion by 2050, with developing countries accounting for a significant increase. Aging is thought to be the greatest risk factor for cardiovascular and neurological diseases, so it is expected to increase the risk of developing these diseases. Furthermore, ageing weakens the immune system and increases the risk of contracting infectious diseases. Furthermore, the growing geriatric population in Asian countries such as China, Japan, and India, which have significant untapped potential, is expected to drive market growth during the forecast period.
Restraints/Challenges
- High R&D costs
High R&D costs for developing novel products and a stringent approval process are impeding market growth. Before being commercialized, the appropriate regulatory authorities must approve novel epigenetic drugs. This framework for drug approval is time-consuming and stringent. There are no clear regulatory policies in place in emerging economies such as China and India, where the diagnostic market has significant growth potential due to a large patient pool. However, a lack of skilled labour and insufficient health insurance coverage in remote areas are two major impediments to the growth of this market.
This epigenome analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the epigenome analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Epigenome Analysis Market
The Covid-19 pandemic had a significant impact on the epigenome analysis market growth. According to a study published in BioMed Central, epigenetic changes may play an important role in the emergence of coronavirus illness consequences. Although several epigenetic therapies are being investigated, more research is required to develop an effective vaccine and safer therapeutic options, including epigenetic treatments, to combat this viral pandemic. As a result, more epigenetics will be used in the identification of COVID-19 infection therapeutics, fueling market growth throughout the forecast period.
Epigenome Analysis Market Scope
The epigenome analysis market is segmented on the basis of technology, component, methods and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Elisa
- ChIP Qpcr
- ChIP‐on‐Chip
- Others
Components
- Ethylation
- Acetylation
- Phosphorylation
- Ubiquitylation
- Sumoylation
Methods
- DNA Methylation Analysis
- Analysis of DNA/Protein Interactions
- Chromatin Accessibility
- Conformation Assays
End Users
- Academic and Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
Epigenome Analysis Market Regional Analysis/Insights
The epigenome analysis market is analyzed and market size insights and trends are provided by country, technology, component, methods and end users as referenced above.
The countries covered in the epigenome analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the epigenome analysis market because of the availability of advanced healthcare facilities and continual advancements in diagnostic procedures.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the rise in the disposable income. Moreover, the growing untapped clinical needs of the patients is further anticipated to grow in the region's epigenetics market in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
表观基因组分析市场还为您提供每个国家医疗支出增长的详细市场分析,包括资本设备、表观基因组分析市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对表观基因组分析市场的影响。数据涵盖 2011-2021 年的历史时期。
竞争格局和表观基因组分析市场份额分析
表观基因组分析市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对表观基因组分析市场的关注有关。
表观基因组分析市场的一些主要参与者包括:
- Illumina 公司(美国)
- 默克集团(德国)
- QIAGEN(德国)
- F. Hoffmann-La Roche Ltd(瑞士)
- 卫材株式会社(日本)
- 诺华公司(瑞士)
- Abcam plc(英国)
- Diagenode sa(美国)
- Active Motif, Inc.(美国)
- Zymo 研究公司。(美国)
- 赛默飞世尔科技(美国)
- Cellcentric(德国)
- Syndax(美国)
- 新英格兰生物实验室(美国)
- Epizyme, Inc.(美国)
- Domainex(英国)
- 安捷伦科技公司(美国)
- PerkinElmer Inc.(美国)
- Bio-Rad Laboratories, Inc.(美国)
- AsisChem Inc.(美国)
- Enzo Life Sciences, Inc.(美国)
- EpiGentek Group Inc.(美国)
- BioVision Inc.(美国)
- Bio-Techne.(美国)
- Promega 公司 (美国)
- GeneTex, Inc.(美国)
- 加州太平洋生物科学公司(美国)
研究方法:全球表观基因组分析市场
数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息,请请求分析师致电或下拉询问。
DBMR 研究团队使用的关键研究方法是数据三角测量,涉及数据挖掘、数据变量对市场影响的分析以及主要(行业专家)验证。除此之外,数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(Factbook)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.